Ally Bridge Group (NY) LLC
CIK: 0001822947Latest portfolio: $96.0M · Q4 2025
Holdings
16
Total Value
$96.0M
New Positions
7
Closed Positions
13
Top Holdings
| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | REPLREPLIMUNE GROUP INC | 1,200,000 | $11.7M | 12.15% | -2,400,000 | Call |
| 2 | EWTXEDGEWISE THERAPEUTICS INC | 445,000 | $11.0M | 11.50% | NEW | Put |
| 3 | ABVXABIVAX SA | 70,000 | $9.4M | 9.83% | NEW | |
| 4 | SLNOSOLENO THERAPEUTICS INC | 168,029 | $7.8M | 8.10% | NEW | |
| 5 | CMPSCOMPASS PATHWAYS PLC | 1,100,000 | $7.6M | 7.91% | -1,072,082 | Call |
| 6 | ATAIATAI BECKLEY NV | 1,713,105 | $7.0M | 7.30% | -573,900 | |
| 7 | IVAINVENTIVA SA | 1,500,000 | $7.0M | 7.27% | NEW | |
| 8 | NERVMINERVA NEUROSCIENCES INC | 1,655,500 | $6.7M | 6.93% | NEW | |
| 9 | PRAXPRAXIS PRECISION MEDICINES I | 19,882 | $5.9M | 6.10% | NEW | |
| 10 | TSHATAYSHA GENE THERAPIES INC | 957,132 | $5.3M | 5.48% | NEW | Call |
| 11 | QUREUNIQURE NV | 200,000 | $4.8M | 4.99% | NEW | Call |
| 12 | EPRXEUPRAXIA PHARMACEUTICALS INC | 397,895 | $3.0M | 3.13% | -517,105 | |
| 13 | OVIDOVID THERAPEUTICS INC | 1,785,000 | $2.9M | 3.03% | NEW | |
| 14 | SLDBSOLID BIOSCIENCES INC | 413,625 | $2.3M | 2.43% | -135,557 | |
| 15 | WHWKWHITEHAWK THERAPEUTICS INC | 817,939 | $2.0M | 2.06% | — | |
| 16 | PMNPROMIS NEUROSCIENCES INC | 249,339 | $1.7M | 1.77% | NEW |
Quarterly Changes
New Positions
Sector Breakdown
Healthcare100.0% ($1.1664110419439778e+56T)
Filing History
Fund Information
Ally Bridge Group (NY) LLC is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $96.0M across 16 holdings. The largest position is REPLIMUNE GROUP INC (REPL), representing 12.2% of the portfolio. Compared to the previous quarter, the fund opened 10 new positions and closed 16 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.